Table 2.

Differentially regulated miRNAs in AIS versus TIA patients.

	Discovery		Validation		Combined
miRNA	FC *	FDR **	FC	FDR	FC	FDR
hsa-miR-548c-5p	1.80	2.44 × 10−2	1.90	1.56 × 10−2	1.70	1.13 × 10−4
hsa-miR-20a-5p	1.69	1.52 × 10−7	1.73	1.19 × 10−4	1.69	1.72 × 10−14
hsa-miR-18a-5p	1.55	2.29 × 10−2	1.73	1.48 × 10−2	1.72	5.01 × 10−6
hsa-miR-484	1.52	1.08 × 10−3	1.55	8.32 × 10−3	1.47	2.64 × 10−6
hsa-miR-652-3p	1.49	4.76 × 10−3	1.62	1.08 × 10−3	1.53	2.31 × 10−7
hsa-miR-486-3p	1.46	3.93 × 10−3	1.49	9.51 × 10−3	1.46	5.73 × 10−7
hsa-miR-24-3p	1.45	3.93 × 10−3	1.63	6.79 × 10−4	1.48	1.13 × 10−7
hsa-miR-181a-5p	1.45	4.25 × 10−3	1.61	1.19 × 10−4	1.44	2.44 × 10−7
hsa-miR-222-3p	1.19	4.46 × 10−2	1.34	3.85 × 10−3	1.24	1.39 × 10−5
hsa-miR-500a-3p	−1.67	1.41 × 10−2	−1.65	4.02 × 10−2	−1.63	8.05 × 10−5
hsa-miR-206	−3.18	3.92 × 10−4	−2.39	2.57 × 10−2	−3.20	2.95 × 10−9

* Fold change. ** False discovery rate.